Advanced in Atherosclerosis

Jae-hwan N. Lee

Yongin, KR 
Clinical Trials:Currently Recruiting for 2 Trials
Advanced in Atherosclerosis
Yongin, KR 
OverviewLocationsClinical Research

Overview

Jae-hwan Lee practices in Yongin, Republic of Korea. Lee is rated as an Advanced expert by MediFind in the treatment of Atherosclerosis. Their top areas of expertise are Peripheral Artery Disease, Coronary Heart Disease, Atherosclerosis, Angioplasty, and Atherectomy.

Their clinical research consists of co-authoring 173 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 20 articles and participated in 2 clinical trials in the study of Atherosclerosis.

Locations

Yongin, Republic of Korea
Other Locations
Seoul, Republic of Korea
Gyeonggi-do, Republic of Korea
Daejeon, Republic of Korea
Sejong, Republic of Korea
Anseong, Republic of Korea
Jungnam, Republic of Korea
Santyoku, Republic of Korea
Chungbuk, Republic of Korea
Cheongju-si, Republic of Korea
Incheon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions; Systemic Chronic Total Occlusion Revascularization Korea Research-Chronic Total Occlusion (STRIKE-CTO) Study
Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions; Systemic Chronic Total Occlusion Revascularization Korea Research-Chronic Total Occlusion (STRIKE-CTO) Study
Enrollment Status: Recruiting
Publish Date: December 27, 2024
Intervention Type: Procedure
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve
Enrollment Status: Recruiting
Publish Date: April 05, 2023
Intervention Type: Device
Study Phase: Not Applicable
The Study for Evaluation of Safety and Efficacy of Transcatheter RF Ablation System (TIRA Catheter) to Treat Hypertrophic Obstructive Cardiomyopathy : Multi-center, Open Label, Single Arm, Investigator Initiated Exploratory Pilot Study
The Study for Evaluation of Safety and Efficacy of Transcatheter RF Ablation System (TIRA Catheter) to Treat Hypertrophic Obstructive Cardiomyopathy : Multi-center, Open Label, Single Arm, Investigator Initiated Exploratory Pilot Study
Enrollment Status: Terminated
Publish Date: April 16, 2025
Intervention Type: Device
Study Phase: Not Applicable
Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion
Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion
Enrollment Status: Active_not_recruiting
Publish Date: April 09, 2025
Intervention Type: Other
Randomized Comparison of Drug-Coated Balloons for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: Prospective, Multicenter, Randomized, Controlled Trial
Randomized Comparison of Drug-Coated Balloons for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: Prospective, Multicenter, Randomized, Controlled Trial
Enrollment Status: Completed
Publish Date: August 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
Perfusion CT Registry
Perfusion CT Registry
Enrollment Status: Completed
Publish Date: March 22, 2023
A Prospective, Multicenter, Single Arm, Post-Market Registry Assessing the Clinical Use and Safety of the LUTONIX Drug Coated Balloon Catheter in Femoropopliteal Arteries
A Prospective, Multicenter, Single Arm, Post-Market Registry Assessing the Clinical Use and Safety of the LUTONIX Drug Coated Balloon Catheter in Femoropopliteal Arteries
Enrollment Status: Completed
Publish Date: July 17, 2020
View 5 Less Clinical Trials

173 Total Publications

Lactiplantibacillus plantarum HY7718 Attenuates Renal Injury in an Adenine-Induced Chronic Kidney Disease Mouse Model via Inhibition of Inflammation and Apoptosis.
Lactiplantibacillus plantarum HY7718 Attenuates Renal Injury in an Adenine-Induced Chronic Kidney Disease Mouse Model via Inhibition of Inflammation and Apoptosis.
Journal: International journal of molecular sciences
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lee's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile